4TS Stock Chart & Stats
€6.97
-€0.13(-1.83%)
At close: 4:00 PM EDT
€6.97
-€0.13(-1.83%)
Day’s Range― - ―
52-Week Range€6.80 - €10.76
Previous CloseN/A
Volume0.00
Average Volume (3M)44.00
Market Cap
€891.72M
Enterprise Value€1.53K
Total Cash (Recent Filing)€67.70M
Total Debt (Recent Filing)€565.00M
Price to Earnings (P/E)13.1
Beta0.41
Next Earnings
Oct 21, 2026EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.64
Shares Outstanding127,036,530
10 Day Avg. Volume0
30 Day Avg. Volume44
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Terveystalo Oy News
4TS FAQ
What was Terveystalo Oy Class A’s price range in the past 12 months?
Terveystalo Oy Class A lowest stock price was €6.80 and its highest was €10.76 in the past 12 months.
What is Terveystalo Oy Class A’s market cap?
Terveystalo Oy Class A’s market cap is €891.72M.
When is Terveystalo Oy Class A’s upcoming earnings report date?
Terveystalo Oy Class A’s upcoming earnings report date is Oct 21, 2026 which is in 84 days.
How were Terveystalo Oy Class A’s earnings last quarter?
Terveystalo Oy Class A released its earnings results on Jul 17, 2026. The company reported €0.128 earnings per share for the quarter, missing the consensus estimate of €0.15 by -€0.022.
Is Terveystalo Oy Class A overvalued?
According to Wall Street analysts Terveystalo Oy Class A’s price is currently Overvalued.
Does Terveystalo Oy Class A pay dividends?
Terveystalo Oy Class A does not currently pay dividends.
What is Terveystalo Oy Class A’s EPS estimate?
Terveystalo Oy Class A’s EPS estimate is 0.12.
How many shares outstanding does Terveystalo Oy Class A have?
Terveystalo Oy Class A has 127,036,530 shares outstanding.
What happened to Terveystalo Oy Class A’s price movement after its last earnings report?
Terveystalo Oy Class A reported an EPS of €0.128 in its last earnings report, missing expectations of €0.15. Following the earnings report the stock price went up 6.676%.
Which hedge fund is a major shareholder of Terveystalo Oy Class A?
Currently, no hedge funds are holding shares in DE:4TS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Terveystalo Oy Class A
Terveystalo Oyj, based in Helsinki, Finland, stands as a leading provider of healthcare services, with a strong focus on occupational health for businesses across the country. Its extensive service portfolio covers general practitioner consultations, specialized medical care, diagnostic procedures, outpatient and day surgery, and a full spectrum of dental and oral health services. The company further extends its offerings to include laboratory and imaging capabilities, wellbeing programs, child welfare services, and various healthcare outsourcing and staffing solutions. Terveystalo also provides modern digital healthcare platforms and engages in clinical research. Serving a diverse clientele, its customers range from private individuals and corporate entities to insurance companies and the public sector. The company maintains a substantial physical presence, operating 360 clinics throughout Finland, which include 18 hospital units, 38 dental clinics, and 73 Rela hierojat massage therapy units. Terveystalo Oyj was established in 2001.
4TS Company Deck
4TS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced picture: significant near-term commercial and volume headwinds impacted revenue, visits (‑6.5%) and profitability, prompting a lowered full‑year adjusted operating profit guidance (EUR 120–140m vs EUR 156m in 2025). Offsetting these negatives, the company highlighted strong cash generation (EUR 175m LTM), secured financing (EUR 550m), high customer satisfaction and medical quality metrics, strategic M&A (Silmäasema and Hohde) to shift mix toward private pay, digital innovation and active cost/efficiency measures. Management expects the larger benefits from sales pipeline and occupational health contract renewals to materialize more in 2027, while near-term recovery is expected primarily in the consumer segment and Sweden.View all DE:4TS earnings summariesTechnical Analysis
1 Day
3 Days
1 Week
1 Month
Terveystalo Oy
―
Siemens Healthineers AG
―
Addus Homecare
―
―
Chemed
―
Healthcare Services
―
Privia Health Group
―







